Logo Unión Europea

Erlotinib Impurity

GA01049 - 98%


In stock
Delivery: 3 to 5 working days
Others quantities on request

Specifications

  • Description

    GA01049

    Erlotinib is a reversible tyrosine kinase inhibitor, it acts on the epidermal growth factor receptor which is highly expressed and occasionally mutated in various forms of cancer. Erlotinib is used to treat non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better. It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche.

    We have successfully synthesized impurities of the Erlotinib as well as the proper Erlotinib subtance. This will be of interest to pharmaceutical companies and analytical labs.

  • Additional information
    Packing Unit

    100 mg, 50 mg

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.